title: Phenytoin in topical formulations augments pain reduction of other topically applied analgesics in the treatment of trigeminal neuralgia.
authors.affiliation: Clinical Operations of the Institute of Neuropathic Pain, Amsterdam, The Netherlands. Electronic address: info@neuropathie.nu.
authors.forename: David J
authors.initials: DJ
authors.lastname: Kopsky
authors.affiliation: Research & Development of the Institute of Neuropathic Pain, Bosch en Duin, The Netherlands.
authors.forename: Jan M
authors.initials: JM
authors.lastname: Keppel Hesselink
mesh_terms: D000279:Administration, Cutaneous; D000368:Aged; D000700:Analgesics / Q000494:pharmacology*; D001418:Baclofen / Q000494:pharmacology; D004357:Drug Synergism; D006801:Humans; D006930:Hyperalgesia / Q000188:drug therapy* / Q000209:etiology; D007649:Ketamine / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009619:Nociceptors / Q000187:drug effects; D059408:Pain Management / Q000379:methods*; D010672:Phenytoin / Q000494:pharmacology*; D063465:Skin Cream / Q000494:pharmacology; D013997:Time Factors; D014110:Touch; D014277:Trigeminal Neuralgia / Q000150:complications / Q000188:drug therapy*
chemical_list: D000700:Analgesics; D010672:Phenytoin; D007649:Ketamine; D001418:Baclofen